Anti-Smith antibodies (anti-Sm) are autoantibodies that target the Smith antigen, a set of small nuclear ribonucleoprotein (snRNP) core proteins found inside the cell nucleus. They are best known as one of the most specific blood markers for systemic lupus erythematosus (SLE).
Key takeaways
Anti-Sm antibodies are highly specific for lupus (they rarely appear in other conditions) but have low sensitivity — only a minority of people with lupus test positive. A positive result strongly supports SLE; a negative result does not rule it out.
What is the Smith antigen?
The Smith antigen was named after a patient, Stephanie Smith, in whom the antibody was first described. It is part of the spliceosome machinery that processes RNA inside cells. Because these proteins are normally hidden inside the nucleus, the immune system should never encounter them — so antibodies against them signal a loss of self-tolerance characteristic of autoimmune disease.
Why anti-Smith antibodies matter in lupus
Anti-Sm is included in the classification criteria used to help diagnose SLE. Its value comes from its specificity: while a positive antinuclear antibody (ANA) test is common and non-specific, a positive anti-Sm result rarely occurs outside of lupus. This makes it a valuable confirmatory marker when lupus is suspected.
Sensitivity vs. specificity
Specificity describes how rarely a test is positive in people who do not have the disease; anti-Sm scores very high here. Sensitivity describes how often the test is positive in people who do have the disease; anti-Sm scores low, because only roughly a quarter to a third of lupus patients carry the antibody. Understanding this trade-off explains why a negative anti-Sm cannot exclude lupus.
Where anti-Smith fits in the testing sequence
- ANA screen: usually the first test; a positive, non-specific result prompts further antibody testing.
- ENA panel: anti-Sm is measured as part of an extractable nuclear antigen (ENA) panel, often alongside anti-dsDNA, anti-RNP, anti-Ro/SSA and anti-La/SSB.
- Clinical correlation: results are interpreted with symptoms such as joint pain, rashes, kidney involvement, and blood-count changes.
A test is not a diagnosis
No single antibody diagnoses lupus. Rheumatologists combine anti-Sm with other antibodies, symptoms, and organ findings using established classification criteria.
What a positive result may lead to
A positive anti-Sm in someone with suggestive symptoms typically leads to a fuller lupus evaluation: assessment of kidney function, complement levels, anti-dsDNA, and monitoring over time. Because lupus is a chronic, relapsing condition, ongoing follow-up with a specialist is the norm.
Frequently Asked Questions
References & Further Reading
Educational disclaimer: This article is for general educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional about your test results and any medical concerns.
